Sakar Healthcare's Secretarial Auditor M/s. Nishant Pandya & Associates Resigns with Immediate Effect

Sakar Healthcare Limited has intimated the stock exchanges of the resignation of its Secretarial Auditors, M/s. Nishant Pandya & Associates, Practising Company Secretaries, with immediate effect from the Financial Year 2025-26 onwards. The resignation letter, dated 6th May, 2026, was submitted by the firm citing personal reasons. The company made this disclosure in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the Listing Regulations and relevant SEBI Circulars.

Resignation Details

M/s. Nishant Pandya & Associates, bearing Membership No. ACS-51005 and COP No. 22435, informed the Board of Directors of Sakar Healthcare that they are no longer associated with the company as Secretarial Auditors for the financial year 2025-26. The firm explicitly stated that there are no other material reasons for the resignation and raised no objection to the appointment of any other Secretarial Auditor by the company.

The key details of the disclosure, as submitted under Annexure 1 in compliance with Regulation 30, are outlined below:

Parameter:	Details
Name of Auditors:	M/s. Nishant Pandya & Associates, Practising Company Secretaries
Reason for Change:	Resignation as Secretarial Auditors with immediate effect due to personal reasons
Date of Cessation:	6th May, 2026 (w.e.f. Financial Year 2025-26 onwards)
Brief Profile (Appointment):	Not Applicable
Director Relationship Disclosure:	Not Applicable

Regulatory Compliance

The intimation was signed and submitted by Bharat Soni, Company Secretary and Compliance Officer of Sakar Healthcare Limited, on 6th May, 2026. The disclosure was addressed to the National Stock Exchange of India Limited in accordance with the applicable listing regulations. The company has requested the exchange to take note of the development in its records.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+16.16%	+25.53%	+12.63%	+76.40%	+124.20%	+421.68%

Sakar Healthcare has notified the National Stock Exchange of India Ltd of an upcoming Board of Directors meeting, scheduled in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted on 6th May, 2026, by Bharat Soni, Company Secretary and Compliance Officer of the company.

Board Meeting Details

The key details of the scheduled board meeting are outlined below:

Parameter:	Details
Meeting Date:	12th May, 2026
Filing Date:	6th May, 2026
Regulatory Reference:	Regulation 29 of SEBI (LODR) Regulations, 2015
Agenda:	Audited Financial Results (Standalone & Consolidated) for FY2025-26
Period Under Review:	Financial Year 2025-26 ended 31st March, 2026

Purpose of the Meeting

The Board of Directors will convene to consider, approve, and take on record the Audited Financial Results — covering both Standalone and Consolidated statements — for the Financial Year 2025-26 ended on 31st March, 2026. The meeting will also address other matters as deemed appropriate by the board.

Trading Window Closure

In compliance with the company's Code of Conduct for prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for designated persons will continue to remain closed. As previously communicated to the Exchange vide letter dated 24th March, 2026, the Trading Window closure will remain in effect until 48 hours after the declaration of the Audited Financial Results for the year ended 31st March, 2026.

The intimation was digitally signed and submitted by Bharat Soni, Company Secretary and Compliance Officer of Sakar Healthcare, on 6th May, 2026.